Scientists from the Beltrao Group at EMBL-EBI and collaborators identified drug targets common to SARS-CoV-2, SARS-CoV-1, and MERS-CoV, three…
Researchers evaluate how the new coronavirus rewires human proteins for its own replication, and identify several antiviral drugs ready for clinical…
EMBL researchers are studying how drugs that have shown good results against COVID-19 work in living…
A rapid, versatile mechanism that modifies proteins is revealed to be crucial for the evolutionary…
CamNTF hosts meetings around Cambridge, open to all scientists interested in new…
3D printing, gaming, virtual reality and lenticular posters bring new perspectives to…
Looking for past print editions of EMBLetc.? Browse our archive, going back 20 years.
EMBLetc. archive